Reshaping Pharmacovigilance in the age of AI

Sameer Lal, Sr. Vice President at Indegene, shares his extensive knowledge in pharmacovigilance and AI from his 27 years in the industry. He talks about a new study illustrating customer perspectives on pharmacovigilance and the challenges in adopting AI technologies, revealing only 5% of organizations have done so. Lal emphasizes AI's potential to enhance data analysis and customer engagement while encouraging upskilling in the workforce. He also compares generative AI's impact on pharma to major tech revolutions, marking an exciting future for innovation.